Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

A lung cancer researcher describes her journey toward a career in science at Novartis.

Meet a Senior Medical Director at Novartis who is part of our new “Women in Science” series

Neurological diseases develop out of sight. Novartis neuroscientists are bringing them into the light, using human brain cells grown in the lab.

Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.